Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Toronto
$120,000.00
Impact of Canadian drug shortages on drug utilization and clinical outcomes
FY 2024-25
Summary
Supervisor: Dr. Mina Tadrous, University of Toronto, Women's College Hospital
One in four Canadians has faced a drug shortage in the last two years, leading the Prime Minister to mandate the Ministry of Health to develop solutions. A drug shortage occurs when the medication supply doesn't meet the current demand, meaning patients might not get the medicines they need, which can harm patient health. Shortages cause patients to use different drugs or stop treatment, which can cause potential side effects, treatment errors, hospitalization and even death. Doctors and pharmacists face extra pressure to find alternatives, which takes time away from direct patient care. Although steps have been taken, like requiring drug companies to report shortages, speeding up drug approvals, and importing drugs, shortages are still common. We still don't fully understand how shortages affect people's access to drugs, their use, or their health.
My research aims to 1) highlight this knowledge gap by reviewing studies on the topic, 2) describe how drug shortages in Canada affect drug use, 3) examine the impact of one of the biggest shortages in Canadian history, the ranitidine recall, on patient care and health outcomes. First, I will review published articles on drug shortages, identifying which drugs were studied, where these studies took place, and what they found. Next, I will analyze drug purchasing data to study Canadian drug shortages from 2017-2021 to understand what factors contribute to shortages and create a model to predict the shortage risk for all Canadian drugs. Finally, I will use Ontario healthcare data to compare the health outcomes of patients using ranitidine to those using alternative drugs during the 2019 ranitidine recall.
My thesis will help our understanding of how shortages occur and factors causing them. These findings will help build policies to prevent and reduce drug shortages, improving patient access to medications and health outcomes.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
518319
Name
Santhireswaran Araniy
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Doctoral Research Awards - B
Projecttitle
Impact of Canadian drug shortages on drug utilization and clinical outcomes
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Biostatistics; Drug Access; Drug Policy; Drug Shortage; Drug Use; Pharmacoepidemiology
Abstract
Supervisor: Dr. Mina Tadrous, University of Toronto, Women's College Hospital
One in four Canadians has faced a drug shortage in the last two years, leading the Prime Minister to mandate the Ministry of Health to develop solutions. A drug shortage occurs when the medication supply doesn't meet the current demand, meaning patients might not get the medicines they need, which can harm patient health. Shortages cause patients to use different drugs or stop treatment, which can cause potential side effects, treatment errors, hospitalization and even death. Doctors and pharmacists face extra pressure to find alternatives, which takes time away from direct patient care. Although steps have been taken, like requiring drug companies to report shortages, speeding up drug approvals, and importing drugs, shortages are still common. We still don't fully understand how shortages affect people's access to drugs, their use, or their health.
My research aims to 1) highlight this knowledge gap by reviewing studies on the topic, 2) describe how drug shortages in Canada affect drug use, 3) examine the impact of one of the biggest shortages in Canadian history, the ranitidine recall, on patient care and health outcomes. First, I will review published articles on drug shortages, identifying which drugs were studied, where these studies took place, and what they found. Next, I will analyze drug purchasing data to study Canadian drug shortages from 2017-2021 to understand what factors contribute to shortages and create a model to predict the shortage risk for all Canadian drugs. Finally, I will use Ontario healthcare data to compare the health outcomes of patients using ranitidine to those using alternative drugs during the 2019 ranitidine recall.
My thesis will help our understanding of how shortages occur and factors causing them. These findings will help build policies to prevent and reduce drug shortages, improving patient access to medications and health outcomes.
Competitiondate
202411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Santhireswaran, Araniy
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~